Daiichi Sankyo Co Ltd (DSNKY)
34.49
+0.85
(+2.53%)
USD |
OTCM |
May 10, 16:00
Daiichi Sankyo Revenue (Quarterly): 2.887B for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 2.887B |
December 31, 2023 | 3.027B |
September 30, 2023 | 2.600B |
June 30, 2023 | 2.557B |
March 31, 2023 | 2.500B |
December 31, 2022 | 2.415B |
September 30, 2022 | 2.371B |
June 30, 2022 | 2.163B |
March 31, 2022 | 2.014B |
December 31, 2021 | 2.472B |
September 30, 2021 | 2.416B |
June 30, 2021 | 2.413B |
March 31, 2021 | 2.112B |
December 31, 2020 | 2.476B |
September 30, 2020 | 2.292B |
June 30, 2020 | 2.202B |
March 31, 2020 | 2.064B |
December 31, 2019 | 2.552B |
September 30, 2019 | 2.147B |
June 30, 2019 | 2.268B |
March 31, 2019 | 2.058B |
December 31, 2018 | 2.273B |
September 30, 2018 | 1.984B |
June 30, 2018 | 2.070B |
March 31, 2018 | 2.022B |
Date | Value |
---|---|
December 31, 2017 | 2.405B |
September 30, 2017 | 2.076B |
June 30, 2017 | 2.152B |
March 31, 2017 | 1.941B |
December 31, 2016 | 2.533B |
September 30, 2016 | 2.121B |
June 30, 2016 | 2.231B |
March 31, 2016 | 1.978B |
December 31, 2015 | 2.303B |
September 30, 2015 | 1.967B |
June 30, 2015 | 1.965B |
March 31, 2015 | 1.888B |
December 31, 2014 | 2.316B |
September 30, 2014 | 2.077B |
June 30, 2014 | 2.092B |
March 31, 2014 | 909.89M |
December 31, 2013 | 2.875B |
September 30, 2013 | 2.671B |
June 30, 2013 | 2.558B |
March 31, 2013 | 2.704B |
December 31, 2012 | 3.220B |
September 30, 2012 | 3.072B |
June 30, 2012 | 3.027B |
March 31, 2012 | 3.058B |
December 31, 2011 | 3.106B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.014B
Minimum
Mar 2022
3.027B
Maximum
Dec 2023
2.397B
Average
2.414B
Median
Revenue (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 7.081B |
Nxera Pharma Co Ltd | 31.07M |
PeptiDream Inc | 41.78M |
Healios KK | 0.0474M |
AnGes Inc | 0.3408M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | 250.42M |
Total Expenses (Quarterly) | 2.772B |
EPS Diluted (Quarterly) | 0.1305 |
Enterprise Value | 58.72B |
Gross Profit Margin (Quarterly) | 75.59% |
Profit Margin (Quarterly) | 8.68% |
Earnings Yield | 2.11% |
Operating Earnings Yield | 2.21% |
Normalized Earnings Yield | 2.106 |